VIM and neoplasm: Staining for EpCAM and CD24 alongside the mesenchymal marker Vimentin in over 12,000 imaging fields from 74 human tumours, stratified on metastatic status, identifies cells that have undergone EMT and disseminated into the stromal region surrounding metastatic primary tumours.